Drinking on the rise among Canada's Gen Z: international survey
Previous research about Gen Z alcohol consumption that painted them as abstainers. For example, in 2020, researchers from the University of Michigan reported that abstention was steadily increasing among college-age Americans. In August 2024, a Gallup study found 65 per cent of U.S. adults under 35 considered drinking unhealthy.
An IWSR research survey conducted in March has turned that picture of Gen Z on its head. 'The idea that Gen Z drinkers are moderating significantly more than other generations isn't backed up by the data in our latest survey,' says Richard Halstead, IWSR's COO Consumer Insights.
IWSR interviewed 1,374 Canadian adults in total for its spring survey. This number was determined to be a representative sample of the national population of adults of legal drinking age in Canada.
The percentage of Canada's Gen Z legal drinking-age (LDA) population who reported drinking rose from 56 per cent in spring 2023 to 69 per cent in spring 2025.
Gen Z drinking more 'is based on what we call 'participation rate,'' says Halstead. To be considered a drinker, respondents must have had one or more drinks in the past six months, he wrote to National Post in an email.
The recent survey found a third of Canadian Gen Z drinkers reported that the last time they drank it was at a bar, restaurant or club — significantly higher than Canadian drinkers as a whole. Nearly four in five reported consuming spirits, which is higher overall than all drinkers in Canada.
The Canadian data for the other generational cohorts shows a small increase among Millennials: 71 per cent (April 2023) to 75 per cent (March 2025). However, alcohol consumption fell for Gen Xers (77 per cent in 2023 to 76 per cent in 2025) and Boomers (76 per cent in 2023 down to 72 per cent in 2025).
IWSR defines these age cohorts as follows: Gen Z (18−27); Millennials (28−43); Gen X (44−59); Boomers (60+).
Increasing income played a role in alcohol consumption among Gen Z drinkers, says Halstead. 'As more Gen Z LDA drinkers approach their mid-twenties, their disposable income is increasing, and that generally correlates with increased alcohol purchases.'
IWSR research says cost-of-living pressures have meant most consumers focused more on buying essentials and staying home, rather than going out drinking.
Otherwise, Halstead says the impact of demographic factors such as gender and household income has 'been fairly consistent in Canada.' Instead, he adds, an increasing number of people are reaching legal drinking age within Gen Z, boosting consumption for that cohort.
Gen Z alcohol consumption is also growing in other key markets. In the U.S., consumption among Gen Z consumers rose from 46 per cent to 70 per cent over the same time-period. In the U.K. it jumped from 66 per cent to 76 per cent, in India up from 60 per cent to 70 per cent and in Australia up from 61 per cent to 83 per cent.
Our website is the place for the latest breaking news, exclusive scoops, longreads and provocative commentary. Please bookmark nationalpost.com and sign up for our daily newsletter, Posted, here.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Associated Press
an hour ago
- Associated Press
5Strands' Pet Test Demonstrates Wellness Benefits in 3rd Party Study
Pet parents across the U.S. are increasingly seeking answers to unexplained skin irritation, digestive distress, and behavioral changes in their pets. With growing awareness of food intolerances and environmental sensitivities, the demand for personalized, non-invasive wellness solutions is rising fast. 5Strands is leading the way with their pet intolerance, sensitivity, and imbalances tests, designed to help pet owners make smarter choices to restore their pet's health and vitality. But, for solutions to truly stand out in a crowded market, science-backed validation is essential. That's where consumer perception studies come into play; offering real-world insight into how products perform in everyday settings. For 5Strands, this kind of research not only supports their product claims but builds trust within the pet health community. In a recent consumer perception study conducted by Citruslabs, the Pet Intolerances & Imbalances Test demonstrated notable improvements in pets' vitality, digestion, and behavior after owners adjusted their pets' diets and environments based on the test results. By Day 45 of using the product: - 81.3% of participants said they would use the test again for other pets. - 71.9% agreed that the test allowed them to make changes that improved their pet's life. - 68.8% would recommend the test to friends and family. - 62.5% of pets experienced no upset stomachs in the last 15 days (up from 44.4% at Baseline). - 81.25% of pets experienced no diarrhea (up from 63.9%), and 65.63% experienced no vomiting (up from 55.6%). 'These results are a strong affirmation of what we hear from customers every day: our test helps pets feel better,' said Austin Collins, CEO at 5Strands. 'We're proud to offer a tool that empowers pet owners to take their pet's health into their own hands with clarity and confidence' Unlike conventional pet wellness products that treat symptoms without addressing root causes, 5Strands' test identifies potential intolerances and imbalances, ranging from food ingredients to environmental factors, so that pet owners can create tailored plans to improve their pets' overall health and comfort. The test also scored highly on user-friendliness: - 100% of participants said the instructions were easy to follow. - 69.4% agreed the test report clear and easy to understand. - 61.1% were able to interpret the results without veterinary assistance. In addition to improvements in digestive and skin health, owners observed increased eagerness to eat and reduced signs of discomfort such as excessive scratching, chewing, or biting of irritated areas. As more pet parents demand proactive, personalized health insights, 5Strands continues to innovate with science at their core. The Citruslabs study confirms that the Pet Intolerances & Imbalances Test is more than just a diagnostic tool, it's a trusted solution for the future of pet wellness. To learn more about 5Strands' pet intolerance, sensitivity, and imbalance tests, visit About 5Strands Founded to revolutionize pet and human health diagnostics, 5Strands offers non-invasive hair testing that uncovers potential intolerances to food and environmental triggers. With easy-to-understand results and actionable insights, 5Strands empowers families to take control of their wellness journeys. Learn more at Media Contact Company Name: 5Strands Contact Person: Lisa Blaurock Email: Send Email Phone: +1 (833) 600-8378 Country: United States Website: Source: Brand Push

Associated Press
an hour ago
- Associated Press
PRIME exits Reveals Why Waiting to Sell Could Be a Million-Dollar Mistake for Healthcare Owners
PRIME exits emphasizes the importance of early planning for healthcare business owners considering an exit. Delaying the process could cost millions. United States, July 7, 2025 -- The PRIME exits Philosophy: Selling Healthcare Companies Requires Engineering, Not Reaction For healthcare business owners—whether operating a medical group, a specialty dental practice, or a thriving behavioral health company—the decision to sell is rarely made lightly. It represents a life-changing turning point. Yet, at PRIME exits, too many owners approach this milestone reactively, driven by burnout, age, or sudden life events—situations where value often erodes. Dr. Allen Nazeri, DDS, MBA, CM&AP—known to clients simply as 'Dr. Allen'—is the Managing Partner at PRIME exits, and a Managing Director at American Healthcare Capital. As a former clinician and serial healthcare entrepreneur turned investment banker, Dr. Allen founded PRIME exits to change how healthcare business owners approach their exits. PRIME exits is not just a healthcare M&A firm; it is a strategic advisor that supports over 52 healthcare verticals with proactive value engineering. What PRIME exits Clients Gain in the Process of Selling Healthcare Companies Reverse-Engineered Exit Strategies for Selling Healthcare Companies Unlike firms that wait until financials are in order and a buyer list is assembled, PRIME exits begins with the end in mind. Each valuation is engineered by identifying inefficiencies, scaling potential, and structuring tax-smart solutions well before a business is listed. This reverse-engineering approach redefines the exit experience. Healthcare-Only Specialization in Selling Healthcare Companies While generalist M&A advisors operate across multiple industries, PRIME exits remains focused exclusively on healthcare. The team possesses deep knowledge of payer mix, clinical KPIs, regulatory risks, patient retention models, and EBITDA adjustments specific to physician, dental, behavioral, and home health practices. Client-Friendly Contracts for Selling Healthcare Companies PRIME exits operates on 30-day renewable agreements, allowing clients to stay because of performance—not legal entanglements. They also fund their own marketing campaigns, underlining confidence in their ability to deliver real results. Confidentiality and Brand Protection in Selling Healthcare Companies No co-brokering. No public ads. PRIME exits begins each process with blind summaries and strict NDAs, ensuring information is shared only with pre-qualified buyers. 'We've built PRIME exits to protect your brand while elevating your value,' says Dr. Allen. Performance-Based Fees for Selling Healthcare Companies PRIME exits charges no upfront retainers or consulting fees. Their compensation is contingent on success—motivating them to maximize every deal for both speed and valuation. Market Access and Mandates in Selling Healthcare Companies With over $1.2 billion in active sell mandates and a growing network of PE firms, strategic consolidators, and family offices, PRIME exits ensures clients are introduced to buyers who appreciate value beyond EBITDA. Value Optimization and Selling Healthcare Companies at Peak Performance Healthcare business owners often plan to sell 'someday,' but someday can be too late. PRIME exits emphasizes exiting while the company—and the founder—are operating at peak performance. Their methodology, referred to as Value Engineering, is designed to elevate operational value before buyers even see the business. Outlined in Dr. Allen's book Value Engineering: Strategies to 10X the Value of Your Clinic and Dominate the Market!, this approach includes: These steps can increase valuation premiums and ensure a smoother transition when the time to sell arrives. Timing Matters: Avoiding the Risks of Delaying the Sale of Healthcare Companies Dr. Allen highlights the '5 D's'—Death, Disability, Divorce, Disagreement, and Distress—as common triggers of rushed, low-value exits. These situations often catch founders unprepared, resulting in regrettable deals. 'With just 12–18 months of preparation, we can often increase the final sale value by 30–50%,' says Dr. Allen. Preparing early allows for cleaning up financials, training successors, de-risking the business, and presenting a compelling, growth-oriented story to buyers. Strategic Representation in Selling Healthcare Companies When working with PRIME exits, clients receive more than an M&A advisor. They gain a partner with firsthand operational, financial, and clinical expertise. Their blind and confidential approach preserves company reputation while driving buyer competition. With private equity and strategic consolidators continuing to seek quality platforms, representation by advisors fluent in healthcare M&A ensures leverage during negotiations and premium closing values. Selling Healthcare Companies on Your Terms While Leverage Remains If a healthcare founder is operating with strong cash flow, a loyal team, and a stable patient base, that's when premium valuations are possible. Delaying until burnout or financial strain sets in only invites buyers looking to exploit distress. At PRIME exits, early preparation, strategic positioning, and rigorous deal-making give clients the upper hand. Whether two or ten years from retirement, beginning today ensures a more successful tomorrow. Start Planning Now: Selling Healthcare Companies Starts with a Valuation Opinion Healthcare entrepreneurs considering a sale within the next 3–5 years are encouraged to seek an expert exit opinion—not just hire a broker. Dr. Allen and PRIME exits offer confidential sessions and free valuation opinions for qualified owners. To learn more, visit or connect with Dr. Allen on LinkedIn. About PRIME exits PRIME exits is a healthcare-focused mergers and acquisitions firm founded by Dr. Allen Nazeri, DDS, MBA, CM&AP. The company, in affiliation with American Healthcare Capital specializes in helping healthcare business owners navigate their exit strategies through a highly personalized and engineered process. With expertise spanning across 52 healthcare verticals, PRIME exits works with its clients to optimize business value, attract top-tier buyers, and secure successful, profitable exits. Media Contact Dr. Allen Nazeri Managing Partner, PRIME exits Email: [email protected] LinkedIin: PRIME exits Contact Info: Name: Dr. Allen Nazeri Email: Send Email Organization: PRIME exits Website: Release ID: 89159932 In the event of encountering any errors, concerns, or inconsistencies within the content shared in this press release, we kindly request that you immediately contact us at [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will be readily accessible to address your feedback within 8 hours and take appropriate measures to rectify any identified issues or facilitate press release takedowns. Ensuring accuracy and reliability are central to our commitment.
Yahoo
2 hours ago
- Yahoo
Bush, Obama and Bono bid farewell to USAID as researchers warn agency's closure means 14m extra deaths
Staff at the U.S. Agency for International Development (USAID) marked their final day on the job on Monday with tributes from two former presidents and a rock legend as new research revealed the stark reality of life without their help. George W Bush, Barack Obama and U2 frontman Bono expressed their thanks to departing employees from the international aid agency in heartfelt video messages as their offices were shuttered under President Donald Trump's 'America First' agenda. Secretary of State Marco Rubio announced in March that 83 percent of USAID's programs would be cut because they did not serve 'the core national interests of the United States,' with the remainder of the agency being folded into his department. But fresh doubt was cast on the wisdom behind that decision by findings published in The Lancet medical journal on the same day staff were saying goodbye, which indicated that 14 million more people will die over the next five years without the humanitarian support USAID once provided. An international team of researchers found the agency's global outreach efforts had prevented 92 million deaths between 2000 and 2021 across 133 countries, saving the lives of 25 million HIV/Aids sufferers, 11 million people with diarrheal diseases, 8 million with malaria and nearly 5 million with tuberculosis. Of the 14 million extra deaths, 4.5 million will be accounted for by children under five, they concluded. Davide Rasella of the Barcelona Institute for Global Health, one of the report's co-authors, called the findings 'striking' and said the likely impact on low and middle-income countries will be 'comparable in scale to a global pandemic or a major armed conflict.' He added that the cuts to USAID 'risk abruptly halting – and even reversing – two decades of progress in health among vulnerable populations.' The agency, founded in 1961, managed a budget of $35bn last year, according to the Congressional Research Service, and was involved in everything from running health clinics and building schools to more mundane but vital tasks like distributing nutrition pouches, mosquito nets and chlorine tablets. 'You've shown the great strength of America through your work, and that is our good heart,' Bush told the outgoing workers on Monday, according to The New York Times, also thanking them for enacting his signature Emergency Plan for Aids Relief. 'Is it in our interest that 25 million people who would have died now live? I think it is,' he said. 'On behalf of a grateful nation, thank you for your hard work, and God bless you.' Obama, in turn, attacked the decision to close USAID as 'a colossal mistake' and lamented: 'Ending your presence and your programs out in the world hurts the most vulnerable, and it hurts the United States. 'To many people around the world, USAID is the United States.' Bono, well known for his advocacy for developing nations, chose to deliver his message in rhyme and said: 'They called you crooks – when you were the best of us, there for the rest of us. And don't think any less of us, when politics makes a mess of us. 'It's not left-wing rhetoric to feed the hungry, heal the sick. If this isn't murder, I don't know what is.' The Lancet's forecast appeared to bear out his assessment and the research it published is by no means the only study to have anticipated such a bleak outcome from USAID's closure. A Boston University model, for instance, has put the human cost of its demise in even more shocking terms: 88 deaths per hour. Amira Albert Roess, a professor of global health and epidemiology at George Mason University, told NBC News it was the speed of the Trump administration's decision that is so dangerous. 'For better or for worse, some of the USAID-funded clinics in some areas, they were the main source of care,' she said. 'If you wanted to reduce USAID funding, it could have been done in a more gradual manner, instead of this sudden – and really, in a lot of places, overnight – shuttering of clinics.' Roess said she was particularly concerned by the abrupt closure of HIV clinics and warned: 'If you miss a dose or multiple doses, as was the case with lots of individuals, that's creating a situation where the individual can start to deteriorate fairly rapidly.' In May, Microsoft co-founder Bill Gates announced he would be bringing forward the charitable donation of $200bn from his personal fortune in order to help meet the shortfall and continue the fight against deadly diseases around the world. In doing so, Gates derided his fellow tech boss Elon Musk for his part in the cuts as the then-leader of Trump's Department of Government Efficiency (DOGE).